MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer.

about

Analysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes.Cytomegalovirus (CMV) Epitope-Specific CD4(+) T Cells Are Inflated in HIV(+) CMV(+) Subjects.

P2860

Q37054621-57B95902-22AC-45FC-A095-808E456984C7 Q41991727-DEB41FD6-4508-4F27-A546-543FC661A1D4

P2860

MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer.

Item

http://www.wikidata.org/entity/Q36579158

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

MHC class II/ESO tetramer-base ...... optive cell therapy of cancer.

@ast

MHC class II/ESO tetramer-base ...... optive cell therapy of cancer.

@en

type

Item

label

MHC class II/ESO tetramer-base ...... optive cell therapy of cancer.

@ast

MHC class II/ESO tetramer-base ...... optive cell therapy of cancer.

@en

prefLabel

MHC class II/ESO tetramer-base ...... optive cell therapy of cancer.

@ast

MHC class II/ESO tetramer-base ...... optive cell therapy of cancer.

@en

P1476

MHC class II/ESO tetramer-base ...... doptive cell therapy of cancer

@en

P2093

Caroline Poli

http://www.w3.org/2001/XMLSchema#string

Danijel Dojcinovic

http://www.w3.org/2001/XMLSchema#string

Danila Valmori

http://www.w3.org/2001/XMLSchema#string

Immanuel Luescher

http://www.w3.org/2001/XMLSchema#string

P2860

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

Tumor-specific Th17-polarized cells eradicate large established melanoma

Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

Phenotypic analysis of antigen-specific T lymphocytes

Cancer/testis antigens, gametogenesis and cancer

Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.

P304

316-322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2012.071712

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maha Ayyoub

Caroline Raffin

P577

2012-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230636846

http://www.w3.org/2001/XMLSchema#string

P698

22875619

http://www.w3.org/2001/XMLSchema#string

P932

3561442

http://www.w3.org/2001/XMLSchema#string

MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer.

about

P2860

P2860

MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932